ACTIVE

Apotheek Pirard Lieve

Financial year 2025 · Closed on 31/12/2025

Net result17,3 k €+595,7 %over 1 year
Revenue1,3 M €+7,4 %over 1 year
Equity-110,1 k €+13,6 %over 1 year

Identity

Source · BCE/KBO

Apotheek Pirard Lieve is a Public limited company incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tienen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0436.153.471
Incorporation
14/12/1988
Legal form
Public limited company
Registered office
Vierde Lansierslaan 6
3300 Tienen · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Joint committees (2)
  • 100
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Revenue1,3 M €1,2 M €839,8 k €723,9 k €665,1 k €
EBITDA60,3 k €55,1 k €74,7 k €60 k €59 k €
Operating result38,3 k €26,5 k €48,6 k €32,6 k €32,8 k €
Net result17,3 k €2,5 k €7,6 k €6,9 k €4,2 k €
Balance sheet
Equity-110,1 k €-127,3 k €-129,8 k €-137,5 k €-144,4 k €
Total assets944,7 k €912,6 k €880,1 k €883,4 k €869,1 k €
Cash12,2 k €14,6 k €11,8 k €32 k €10,2 k €
Debts1,1 M €1 M €1 M €1 M €1 M €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 13 ended

Active mandates

Carine Knapen

Mandate

Active
SCHREVENS - Beheer

Mandate · 0444.719.957

Active
Theo Schrevens

Mandate

Active

Ended mandates

Jo Kempeneers

Director · since 01 octobre 2014 · until 01 juin 2020

Ended
Ellepharma

Managing director · since 22 juin 2013 · until 22 juin 2019 · 0474.402.848

Represented by Godelieve Pirard

Ended
Liliane Koekelkoren

Director · since 22 juin 2013 · until 22 juin 2019

Ended
Ellepharma

Managing director · since 03 juin 2013 · until 03 juin 2019 · 0474.402.848

Represented by Pirard Godelieve

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/08/202601/10/202520/09/202409/10/202317/10/202230/09/2021
General meeting17/08/202618/09/202515/08/202409/10/202318/08/202219/08/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202517/08/202617/08/2026DutchPDF
Micro model31/12/202418/09/202501/10/2025DutchPDF
Micro model31/12/202315/08/202420/09/2024DutchPDF
Micro model31/12/202209/10/202309/10/2023DutchPDF
Micro model31/12/202118/08/202217/10/2022DutchPDF
Micro model31/12/202019/08/202130/09/2021DutchPDF
Abridged model31/12/201920/08/202026/08/2020DutchPDF
Abridged model31/12/201819/09/201907/10/2019DutchPDF
Abridged model31/12/201702/08/201826/09/2018DutchPDF
Abridged model31/12/201622/06/201718/07/2017DutchPDF
Abridged model31/12/201501/06/201631/08/2016DutchPDF
Abridged model31/12/201401/06/201523/09/2015DutchPDF
Abridged model31/12/201302/06/201430/09/2014DutchPDF
Abridged model31/12/201203/06/201330/09/2013DutchPDF
Abridged model31/12/201101/06/201203/12/2012DutchPDF
Abridged model31/12/201001/06/201105/07/2011DutchPDF
Abridged model31/12/200901/06/201010/06/2010DutchPDF
Abridged model31/12/200802/06/200909/06/2009DutchPDF
Abridged model31/12/200702/06/200817/06/2008DutchPDF
Abridged model31/12/200622/06/200705/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 13 ended

Active mandates

Carine Knapen

Mandate

Active
SCHREVENS - Beheer

Mandate · 0444.719.957

Active
Theo Schrevens

Mandate

Active

Ended mandates

Jo Kempeneers

Director · since 01 octobre 2014 · until 01 juin 2020

Ended
Ellepharma

Managing director · since 22 juin 2013 · until 22 juin 2019 · 0474.402.848

Represented by Godelieve Pirard

Ended
Liliane Koekelkoren

Director · since 22 juin 2013 · until 22 juin 2019

Ended
Ellepharma

Managing director · since 03 juin 2013 · until 03 juin 2019 · 0474.402.848

Represented by Pirard Godelieve

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates02/07/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office01/09/2015
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates05/03/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/03/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/08/2007
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/12/2004
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202517,3 k €↑
  2. 2024
    Annual accounts 20242,5 k €↓
  3. 2023
    Annual accounts 20237,6 k €↑
  4. 2022
    Annual accounts 20226,9 k €↑
  5. 2021
    Annual accounts 20214,2 k €↓
  6. 2020
    Annual accounts 20205,6 k €↑
  7. 2019
    Annual accounts 2019-21,9 k €↑
  8. 2018
    Annual accounts 2018-31,2 k €↓
  9. 2017
    Annual accounts 2017130,8 k €↑
  10. 2016
    Annual accounts 2016-70 k €↑
  11. 2015
    Annual accounts 2015-86,6 k €↓
  12. 2014
    Annual accounts 2014-5,3 k €↑
  13. 2013
    Annual accounts 2013-7,4 k €↑
  14. 2012
    Annual accounts 2012-159,7 k €↓
  15. 2011
    Annual accounts 2011-38,7 k €↓
  16. 2010
    Annual accounts 201031,6 k €↓
  17. 2009
    Annual accounts 200935,4 k €↑
  18. 2008
    Annual accounts 2008-3,6 k €↓
  19. 2007
    Annual accounts 2007129 k €↑
  20. 2006
    Annual accounts 200635,2 k €
  21. 14/12/1988
    IncorporationPublic limited company